Dr. Eric Lawrence Simpson, MD

Dr. Simpson practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Simpson's NPI, 1972511426, was assigned on August 3, 2006. Dr. Simpson graduated from University of Texas Southwestern Medical School at Dallas in 1998. Dr. Simpson holds Oregon license MD23920.

Dr. Simpson's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Simpson's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Simpson to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simpson practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Simpson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Simpson is licensed in Oregon.

CMS data shows 1,492 Medicare services from Dr. Simpson across 13 procedure codes in 2024, for 403 Medicare patients. Medicare paid $43,195 for them. Every service was in an office.

CMS counts 403 Medicare patients who saw Dr. Simpson in 2024. The largest group is 75 to 84, with 174 patients. 57% of them have high cholesterol, and 55% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Simpson's median patient age at 74, with 46% women.

In 2024, Dr. Simpson wrote 423 Medicare Part D claims for 128 patients. 65% of them were for generic drugs. CMS names the drug for 258 of them, across 7 drugs with 11 or more claims each, at $371,967 in total drug cost. In 2023, CMS named 360 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Simpson for performance year 2024, reported through an alternative payment model (APM). Dr. Simpson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Simpson as offering telehealth. CMS counts 413 procedures of removal of skin lesions by Dr. Simpson, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 334 papers to Dr. Simpson, published from 2010 to 2025. 2021 was the busiest year, with 33. The most frequent topics are Dermatitis, Atopic, Double-Blind Method and Eczema. Dr. Simpson has published most often in J Am Acad Dermatol. Dr. Simpson's most frequent co-authors are Lawrence F. Eichenfield, MD, Andrew Blauvelt, MD and Jon Michael Hanifin, MD.

Dmand AI links Dr. Simpson to 25 clinical trials. 2 are still active or recruiting. Conditions studied include Dermatitis, Atopic, Eczema and Skin Diseases, Eczematous. Regeneron Pharmaceuticals sponsors the most, 14. Open Payments lists research payments to Dr. Simpson that name 16 trials.

CMS Open Payments shows 1,192 general payments to Dr. Simpson from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Sanofi and Genzyme US Companies paid the most, $698,172. It also lists 658 research payments totaling $490,005 from 2016 to 2025, naming 16 clinical trials.

Dr. Simpson graduated from University of Texas Southwestern Medical School at Dallas in 1998.